Latest Breaking News On - Milind deshpande - Page 1 : vimarsana.com

MMS roundtable: Digital labels vs flexo, a comparative analysis

Hosted by the Mumbai Mudrak Sangh (MMS), the seventh edition of its Roundtable Conference convened on 5 April, 2024 at MCA Club, BKC, Mumbai. 'Circle of Print' themed discussion involved industry stalwarts to explore trends and challenges on the ‘digital label and flexo’ table.

Spero Therapeutics, Inc. (NASDAQ:SPRO) Q3 2023 Earnings Call Transcript

Ted Jenkins: Thank you, operator, and thank you all for participating in today's conference call.

Chinese whispers of the printing type - The Noel D'Cunha Sunday Column

At least 1,000 members of the printing and packaging industry, who were to travel to Shanghai for the All in Print expo, were left stranded across the country on 30 October.

Printers across India can't travel to China as confusion reigns

In a development which is an embarrassment to the Indian print and packaging industry, besides inconveniencing hundreds of business travellers due to the last minute cancellations because the Indian immigration officials in airports across major cities in India reportedly refused 400+ Indian print firm CEOs and packaging converters owners to board their flights to China. The Indian print and packaging fraternity was on the way to China to participate in the All In Print exhibition in Shanghai wh

Form 8-K Spero Therapeutics, Inc. For: Oct 05

Hyku Biosciences, Inc.: Hyku Biosciences Launches With $56M to Advance its Covalent Medicines Platform to Expand the Boundaries of Drug Discovery

Hyku Biosciences Launches With $56M to Advance its Covalent Medicines Platform to Expand the Boundaries of Drug Discovery

Hyku Biosciences Launches With $56M to Advance its Covalent Medicines ...

Hyku Biosciences Launches With $56M to Advance its Covalent Medicines ...

Hyku Biosciences Launches With $56M to Advance its Covalent Medicines Platform to Expand the Boundaries of Drug Discovery

Hyku Biosciences, Inc.: Hyku Biosciences Launches With $56M to Advance its Covalent Medicines Platform to Expand the Boundaries of Drug Discovery